Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Unlocking the potential of your asset management business.|Mathias Österberg, CEO, GRIT Governance
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Mathias Österberg is the CEO of GRIT Governance.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
help technical founders turn machine learning models|Mark Gorenberg,Managing Director,Zetta Venture Partners
00:10:00
Copper Bank Corp.: Strategic Focus on Non-Dilutive, High-Yield Copper Investments
00:10:00
Alstom CEO Discusses Bombardier Acquisition on "Good Morning Business | Henri Poupart Lafarge - CEO of Alstom
00:10:00
Perpetual Expands Horizons: Acquisition of Trillium Asset Management | Rob Adams, CEO , Perpetual Limited .
00:10:00
Marc Andreessen's Top Investment Insights: Lessons Learned and Timeless Advice from the Co-Founder of Andreessen Horowitz on Bloomberg Wealth with David Rubenstein
00:10:00
"Maximize Your Tax Savings in 2020: Expert Tips from Cogent Strategic Wealth"
00:10:00
Exploring Far Resources: Promising Lithium Projects in Manitoba
00:10:00
Improves the readability and flow of the transcript while ensuring that all critical details are included|CEO, BK Holdings Co Ltd
00:10:00
Shivam: Ensuring Smooth Transactions in Corporate Investment Banking
00:10:00
A Pillar of Australia's Financial Sector and Community Leadership|Chairman ,BWP Trust
00:10:00
"PagerDuty CEO Jennifer Tejada affirms the company's strong performance despite a challenging macro environment."|Jennifer Tejada is the Chairperson and CEO of PagerDuty
00:10:00
Aurania Resources: Exploring Ecuador's Lost City and Gold-Silver Targets